David T. Purtilo

8.7k total citations · 2 hit papers
173 papers, 6.4k citations indexed

About

David T. Purtilo is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, David T. Purtilo has authored 173 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 79 papers in Immunology and 54 papers in Pathology and Forensic Medicine. Recurrent topics in David T. Purtilo's work include Viral-associated cancers and disorders (93 papers), Lymphoma Diagnosis and Treatment (48 papers) and Immune Cell Function and Interaction (41 papers). David T. Purtilo is often cited by papers focused on Viral-associated cancers and disorders (93 papers), Lymphoma Diagnosis and Treatment (48 papers) and Immune Cell Function and Interaction (41 papers). David T. Purtilo collaborates with scholars based in United States, Japan and Sweden. David T. Purtilo's co-authors include Kiyoshi Sakamoto, Douglas W. Hanto, Richard L. Simmons, John L. Sullivan, Samuel M. Cohen, Motohiko Okano, Lawrence M. Weiss, John G. Strickler, Jeffrey Sklar and Glauco Frizzera and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David T. Purtilo

170 papers receiving 5.9k citations

Hit Papers

Epstein-Barr viral DNA in tissues of Hodgkin's disease. 1981 2026 1996 2011 1987 1981 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David T. Purtilo United States 44 3.4k 2.0k 2.0k 1.5k 1.4k 173 6.4k
William H. Burns United States 36 1.7k 0.5× 1.4k 0.7× 741 0.4× 2.3k 1.6× 557 0.4× 85 5.7k
Ronald T. Mitsuyasu United States 48 3.0k 0.9× 3.3k 1.6× 898 0.5× 2.4k 1.7× 2.6k 1.9× 178 10.3k
Gary R. Pearson United States 43 3.4k 1.0× 1.3k 0.6× 1.3k 0.6× 2.4k 1.6× 1.6k 1.2× 142 6.2k
George Miller United States 58 9.7k 2.8× 2.2k 1.1× 3.0k 1.5× 5.7k 3.9× 3.7k 2.7× 196 12.2k
Hirokazu Kanegane Japan 44 2.1k 0.6× 4.0k 2.0× 887 0.5× 820 0.6× 893 0.6× 308 7.4k
Jan Storek Canada 45 2.0k 0.6× 3.0k 1.5× 749 0.4× 2.4k 1.7× 875 0.6× 187 7.6k
Seiji Kojima Japan 47 2.3k 0.7× 1.5k 0.7× 771 0.4× 1.3k 0.9× 865 0.6× 325 8.1k
Rosemary Rochford United States 41 2.3k 0.7× 2.0k 1.0× 1.2k 0.6× 2.0k 1.3× 882 0.6× 141 5.9k
Thomas A. Fleisher United States 53 1.8k 0.5× 5.6k 2.7× 558 0.3× 1.0k 0.7× 613 0.4× 163 8.1k
Richard J. O’Reilly United States 54 3.8k 1.1× 5.0k 2.4× 604 0.3× 2.4k 1.7× 652 0.5× 295 10.7k

Countries citing papers authored by David T. Purtilo

Since Specialization
Citations

This map shows the geographic impact of David T. Purtilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Purtilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Purtilo more than expected).

Fields of papers citing papers by David T. Purtilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Purtilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Purtilo. The network helps show where David T. Purtilo may publish in the future.

Co-authorship network of co-authors of David T. Purtilo

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Purtilo. A scholar is included among the top collaborators of David T. Purtilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Purtilo. David T. Purtilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okano, Motohiko, et al.. (1992). Early activation of the proto-oncogene c-fgr during Epstein-Barr virus immortalization. Cancer Letters. 64(1). 11–15. 1 indexed citations
2.
Purtilo, David T.. (1991). X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology. Springer Seminars in Immunopathology. 13(2). 181–197. 23 indexed citations
3.
Okano, Motohiko, Rifaat Bashir, Jack R. Davis, & David T. Purtilo. (1991). Detection of primary epstein‐barr virus infection in a patient with x‐linked lymphoproliferative disease receiving immunoglobulin prophylaxis. American Journal of Hematology. 36(4). 294–296. 14 indexed citations
4.
List, Alan F., et al.. (1990). Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus.. PubMed. 3(5). 609–12. 16 indexed citations
5.
Grierson, Helen L., David T. Purtilo, J Pierson, et al.. (1990). Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.. PubMed. 50(16). 4845–8. 13 indexed citations
6.
Okano, Motohiko, Geoffrey M. Thiele, & David T. Purtilo. (1990). Severe Chronic Active Epstein-Barr Virus Infection Syndrome and Adenovirus Type-2 Infection. Journal of Pediatric Hematology/Oncology. 12(1). 168–173. 12 indexed citations
7.
Purtilo, David T., et al.. (1990). Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.. Environmental Health Perspectives. 88. 225–230. 13 indexed citations
8.
Okano, Motohiko, et al.. (1990). Adenovirus infection in patients with Kawasaki disease. Journal of Medical Virology. 32(1). 53–57. 32 indexed citations
9.
Okano, Motohiko, Geoffrey M. Thiele, Thomas G. Gross, Jack R. Davis, & David T. Purtilo. (1990). Differential cellular susceptibility to Epstein‐Barr virus infection in a patient with X‐linked lymphoproliferative disease. Journal of Medical Virology. 32(1). 47–52. 9 indexed citations
10.
Purtilo, David T., Helen L. Grierson, Hans D. Ochs, & James Skare. (1989). Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markers☆. The American Journal of Medicine. 87. 421–424. 2 indexed citations
11.
Watson, Patrice, et al.. (1989). Genetic and immunopathological findings in a lymphoma family. British Journal of Cancer. 59(4). 622–626. 7 indexed citations
12.
Markin, Rodney S., James Linder, Elizabeth Mroczek, et al.. (1987). Hepatitis in fatal infectious mononucleosis. Gastroenterology. 93(6). 1210–1217. 71 indexed citations
13.
Ellwein, Leon B., David T. Purtilo, & Ruth Purtilo. (1986). DECISION ANALYSIS OF THE HTLV-III SCREENING TEST FOR BLOOD DONORS. PubMed. 2(1). 5–17. 1 indexed citations
14.
Feusner, James H., Shinji Harada, Warren G. Sanger, et al.. (1984). Fatal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. The Journal of Pediatrics. 105(1). 64–67. 19 indexed citations
17.
Tatsumi, E, Shinji Harada, Joanne Yetz, et al.. (1983). EPSTEIN-BARR VIRUS AND CHRONIC LYMPHADENOMEGALY IN MALE HOMOSEXUALS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS). PubMed. 1(1). 59–82. 21 indexed citations
18.
Purtilo, David T., Shinji Harada, E Tatsumi, et al.. (1983). HUMAN T CELL LEUKEMIA VIRUS-1 ANTIBODIES NOT DETECTED IN AIDS. PubMed. 1(4). 237–241. 1 indexed citations
19.
Casareale, D, Stephen Dewhurst, Joseph Sonnabend, et al.. (1983). PREVALENCE OF AIDS-ASSOCIATED RETROVIRUS AND ANTIBODIES AMONG MALE HOMOSEXUALS AT RISK FOR AIDS IN GREENWICH VILLAGE. PubMed. 1(6). 407–421. 23 indexed citations
20.
Saemundsen, Ari K., David T. Purtilo, Kiyoshi Sakamoto, et al.. (1981). Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.. PubMed. 41(11 Pt 1). 4237–42. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026